Zekan J, Skerlev M, Milic L, et al. Human papillomavirus⁃related diseases of the female lower genital tract: oncogenic aspects and molecular interaction[J]. Coll Antropol, 2014, 38(2): 779⁃786.
[2]
Stupack DG. Caspase⁃8 as a therapeutic target in cancer[J]. Cancer Lett, 2013, 332(2): 133⁃140. DOI: 10.1016/j.canlet. 2010.07.022.
[3]
Tian F, Lu J, Wang L, et al. Increased of cellular FLICE/caspase⁃8 inhibitory protein in condyloma acuminatum[J]. Eur J Dermatol, 2011, 21(4): 529⁃533. DOI: 10.1684/ejd.2011.1378.
Lubahn J, Berndt SI, Jin CH, et al. Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma[J]. Prostate, 2010, 70(6): 646⁃653. DOI: 10.1002/pros.21098.
[6]
Baker E. HPV and Pap: shifting roles in cervical cancer screening[J]. MLO Med Lab Obs, 2013, 45(11): 24, 26.
[7]
Yuan CH, Filippova M, Tungteakkhun SS, et al. Small molecule inhibitors of the HPV16⁃E6 interaction with caspase 8[J]. Bioorg Med Chem Lett, 2012, 22(5): 2125⁃2129. DOI: 10.1016/j.bmcl. 2011.12.145.
[8]
Briest F, Grabowski P. PI3K⁃AKT⁃mTOR⁃signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms[J]. Theranostics, 2014, 4(4): 336⁃365. DOI: 10.7150/thno.7851.